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CASE  REPORT
UMBILICAL MASS AS THE SOLE PRESENTING
SYMPTOM OF PANCREATIC CANCER: A CASE
REPORT
Fábio Crescentini, Fernanda Deutsch, Carlos Walter Sobrado and Sérgio de Araújo
CRESCENTINI F et al. Umbilical mass as the sole presenting sign of pancreatic cancer: a case report. Rev. Hosp. Clín. Fac.
Med. S. Paulo 59(4):198-202, 2004.
Umbilical nodes are rare. The metastatic involvement of the region was first described in 1846. Sister Mary Joseph was
the first observer to establish the correlation between carcinomas and umbilical nodes. The umbilical node may be the sole
presenting sign of cancer and is usually associated with advanced disease and poor prognosis.
A 64-year-old woman, previously healthy, presented vague abdominal discomfort and a hard umbilical nodule for 1
week, which was first diagnosed as an incarcerated umbilical hernia. She underwent a new clinical assessment and biopsy.
After immunohistochemical analysis and computerized tomography, she was diagnosed with pancreatic cancer.
The clinical staging showed advanced disease with distant metastasis. She received palliative chemotherapy. After 8
months, she was alive in poor clinical condition.
Clinical suspicion should lead to a careful additional evaluation whenever an umbilical nodule presents with malignant
signs.
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Tumors of the umbilicus are rare.
The metastatic involvement of the re-
gion due to visceral carcinomas is even
less frequent.1,2 The first medical report
of such a condition was by Walshe et
al. in 1846, through the Tanchov’s re-
view of data. The author found only 2
cases of umbilical involvement among
9118 deaths from cancer in the period
of 1830 to1840.¹ In 1864 Storer et al.
reported the first complete case study
of a metastatic umbilical nodule due
to gastric adenocarcinoma.³ However,
the association of umbilical masses
and visceral carcinomas was firmly es-
tablished after the clinical observa-
tions of a nurse from the Mayo Clinic
(Rochester, USA). Her name was attrib-
uted to this clinical feature, which was
designated as “Sister Mary Joseph’s”
sign.
Even though it is a rare clinical
finding, an umbilical mass may be the
sole presentation of malignant
tumors.4,5 Shetty¹ reviewed all cases re-
lated to “Sister Mary Joseph’s nodule”
published until 1989. This review
found a total of 265 cases and 85 nod-
ules from unknown primary tumors.
Concerning pancreatic tumors, only 12
cases had been reported.3-10 We found
only 1 description¹¹ since 1989, and in
1998 the metastatic involvement of the
umbilicus from a pancreatic cancer
was exhibited as the image of the
month in Gastroenterology¹². We un-
dertook this bibliographic research us-
ing the PubMed database and the fol-
lowing keywords: “Sister Mary
Joseph’s nodule”, unknown primary
tumor, pancreatic cancer, umbilical
metastasis.
A careful clinical examination and
extensive diagnostic procedures
should be performed for all patients
presenting with umbilical nodules. To
illustrate and emphasize this point, we
report a case of an umbilical mass as
the only presenting sign of adenocar-
cinoma of the pancreas.
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DESCRIPTION OF THE CASE
A 64-year-old woman presented
with a 3-month history of vague ab-
dominal discomfort in the epigastric
region, with no irradiation sites, slowly
progressive, and not related to food in-
take. She had noticed an umbilical
nodule the previous week. She did not
present with weight loss, fever, or other
systemic symptoms. She denied hav-
ing cardiorespiratory discomfort or
gastrointestinal complaints. Her refer-
ral doctor (general practice) first diag-
nosed the mass as an incarcerated um-
bilical mass. A surgeon re-examined
and re-evaluated the patient. She pre-
sented in good general condition, well
nourished, no palpable masses at the
cervical, abdominal, or thoracic re-
gions. On physical examination, a
peri-umbilical nodule of 2 by 2 cm was
noted, which was hyper-pigmented,
indurated, discretely painful, and pro-
duced a fetid discharge.
Routine laboratory investigation
showed normal results. The
sonographic scan of the abdomen
showed no abnormalities. At the first
physical and laboratory investigation,
the patient presented evidence of
tumoral disease, with unknown pri-
mary tumor. Therefore, the umbilical
nodule was resected for diagnostic
purposes and an anatomic-pathologic
analysis was performed (Figure 1),
which showed a mucinous, poorly dif-
ferentiated metastatic adenocarci-
noma, suggestive of a GI tract (stom-
ach or pancreas) or ovarian cancer. Im-
munohistochemical analysis was posi-
tive for cytokeratin 7 and negative for
cytokeratin 20. This finding suggested
a primary site at stomach or pancreas.
Due to the anatomic-pathologic
findings, an abdominal CT scan was
performed. The exam showed a cystic
and solid tumor of 6 cm in the pancre-
atic body (Figure 2). For staging pur-
poses, a thoracic CT scan was also per-
formed, and several pulmonary nod-
ules, diagnosed as metastases, were en-
countered (Figure 3). The brain CT
scan showed no abnormalities.
The patient was referred to the
medical oncology service for pallia-
tive chemotherapy because of ad-
vanced pancreatic cancer with perito-
neal dissemination and lung
metastases. Even though the patient
was alive 8 months after the diagno-
sis, she progressively deteriorated and
presented in poor clinical condition.
She had undergone thoracocentesis 3
times for relief of severe dyspnea.
Figure 2 – Abdominal CT scan with IV contrast (cystic lesion with solid components in the
pancreatic body).
Figure 1 – Resected nodule (hardened and dark).
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DISCUSSION
The finding of an umbilical nod-
ule as the only clinical manifestation
of a disease leads to several possible
diagnoses including umbilical hernia,
granuloma, attachments of the urachus,
pilonidal sinus, omphalomesenteric
duct abnormalities, endometriosis, and
benign and malignant tumors.7-13 Be-
nign lesions are diagnosed in the vast
majority of cases, and the finding of
the metastatic involvement of the um-
bilical region is rare.8-14 Shetty et al.
reviewed all cases of malignant disease
at the umbilicus from 1830 to 1989
and found only 265 cases previously
published; 85 cases of umbilical me-
tastasis from unknown primary origin
were found.¹
Several modes of spreading to the
umbilicus have been discussed. Metas-
tasis to the umbilicus may occur due
to proximity to the tumor,
hematogenic and lymphatic dissemi-
nation, or via umbilical ligaments. The
most prevalent form of umbilical in-
volvement is related to direct invasion
of peritoneal metastasis. The retro-
grade flux from superficial and deep
lymphatic systems originated at axil-
lary, inguinal, and para-aortic nodes
may lead to umbilical involvement.
Another possible form involves venous
communication between the lateral
thoracic veins and internal mammary
vein with the portal circulation.14
Therefore, theoretically, all types of
cancer may disseminate to the umbili-
cal region. However, the most preva-
lent primary sites are from intra-ab-
dominal origin. Shetty (1990) re-
viewed cases of umbilical metastasis
previously published and found that
42% originated at the abdomen or pel-
vis, mainly from the GI tract, classified
as follows: gastric cancer 17%, large
bowel 6%, pancreas 6%, gallbladder
3%, and small bowel 1%. He also
found a large prevalence among tumors
from the female genital tract, account-
ing for 9% of all cases. Other primary
sites, such as lung, cervix, fallopian
tube, and melanoma were rare and rep-
resented 1% of patients. However, this
data should be analyzed cautiously
since it was partially obtained before
modern radiological techniques.
Nearly 30% of cases had an unknown
primary site.¹ In the present case report,
the lymphatic spread from the pancre-
atic body to the umbilicus originated
mostly through the splenic and para-
aortic nodes, as described by Donatini
et al.15 Although there were no signs
of carcinomatosis in the reported case,
the umbilical involvement due to
proximity to the primary site should
always be investigated.
The metastatic umbilical nodule,
known as Sister Mary Joseph’s nodule,
is morphologically firm, an indurated
plaque or nodule with a vascular ap-
pearance, and may be fissured and ul-
cerated with some fetid discharge.
However, it may also present as an un-
characteristic diffuse hardening of the
umbilical region or as a profound
node.16 Steck et al. observed that in
45% of their patients, the umbilical
node was the only clinical sign of can-
cer. This figure demonstrates the im-
portance of an evaluation of all um-
bilical lesions, especially in patients
after the fifth decade of life.¹³
For diagnostic purposes, radiologi-
cal methods and the anatomic-patho-
logical analysis are extremely impor-
tant. The microscopic analysis is espe-
cially attractive in such cases due to the
favorable localization of umbilical
nodes. The usual evaluation with
hematoxylin-eosin may differentiate
primary and metastatic tumors. Moreo-
ver, immunohistochemical analysis may
define the cellular origin in 72% of
cases of unknown primary tumor.17 The
use of electronic microscopy and cy-
togenetic analysis may enhance the di-
agnostic sensitivity and specificity of
the diagnosis. Edoute et al. Analyzed
the cytologic material of 14 patients
using fine-needle aspiration. The
method had a sensitivity as high as
92.8% and a positive predictive value
of 100%. Only 1 case was diagnosed as
a false negative, since na inflammatory
cell-containing aspiration was ob-
tained.² Therefore, although it is a safe
diagnostic method, the cytologic evalu-
ation using fine-needle aspiration
Figure 3 – Thoracic CT scan (pulmonary window) - several nodules (suggestive of metastases).
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should be properly indicated and may
not replace the full anatomic-
pathologic analysis. Moreover, radio-
logical exams, such as ultrasound
imaging, CT scan, or MRI have a poor
cost-benefit relationship due to their
low diagnostic power. Those methods
should be preserved for staging pur-
poses or for special cases when the pa-
thologist evaluation is not possible.
The metastatic spread to the um-
bilical region representnaan advanced
stage of the primary disease and wors-
ened prognosis. Consequently, pallia-
tive treatment is usually the only re-
maining therapeutic option. However,
as previously discussna, an umbilical
nodule may be the only presenting
sign of cancer, enhancing the diagno-
sis before the appearance of more exu-
berant features, such as ascites, pulmo-
nary masses, and bone metastasis,
which are responsible for decreased
quality of life and overall survival
even after the administration of pallia-
tive treatment.
Even though it is a rare finnang, an
umbilical mass may be the first mani-
festation of neoplastic disease, as was
observed in the present case. Therefore,
the clinical suspicion and diagnostic
evaluation are extremely important for
therapeutic and prognostic purposes.
RESUMO
CRESCENTINI F e col. Nódulo um-
bilical como única apresentação
clínica de tumor pancreático:
relato de caso. Rev. Hosp. Clín.
Fac. Med. S. Paulo 59(4):198-202,
2004.
Nódulos umbilicais são raros. Des-
de 1846, o comprometimento metas-
tático da região vem sendo descrito. A
Irmã Mary Joseph foi a primeira a re-
lacionar o aparecimento de nódulos
umbilicais com carcinomas. Esses nó-
dulos podem ser a única manifestação
de câncer, normalmente associada a
estadios avançados e pior prognóstico.
Uma senhora de 64 anos, previa-
mente hígida, apresentava desconfor-
to abdominal inespecífico e apareci-
mento de nódulo umbilical endureci-
do há uma semana. O diagnóstico ini-
cial foi hérnia umbilical encarcerada.
Após reavaliação, o nódulo foi biop-
siado, cujo exame anátomo-patológi-
co demonstrou carcinoma com sítio
primário desconhecido. Á análise
imuno-histoquímica e tomografia, o
diagnóstico foi carcinoma de pâncre-
as. O estadiamento demonstrou doen-
ça avançada, com metastáses à distân-
cia. A paciente foi submetida a qui-
mioterapia paliativa. Após 8 meses,
encontrava-se em mau estado geral.
A suspeita clínica deve originar
avaliação clínica cuidadosa, auxiliada
por exames subsidiários, sempre que
um nódulo umbilical apresentar sinais
de malignidade.
UNITERMOS: Nódulo Sister
Mary Jpseph. Massa umbilical. Tu-
mor primário desconhecido. Cancer.
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